Understanding the Role of JAK Inhibitors

James Q. Del Rosso, DO, and Neal Bhatia, MD, provide an overview of JAK inhibitors for the treatment of atopic dermatitis.

A review of topical JAK inhibitor ruxolitinib.

Experts discuss newly approved oral JAK inhibitors for the treatment of atopic dermatitis.

Drs James Q. Del Rosso and Neal Bhatia explain how to manage patients who fail therapy and provide safety considerations when treating those patients.